Inter-CFAR HIV/TB Working Group National Meeting
John P. McGovern Texas Medical Center Commons Building
Trevisio Conference Room Roma
6550 Bertner Ave, Suite 602
Houston, TX 77030
September 30, 2009
The purpose of the Inter-CFAR Working Group meeting is to bring together CFAR investigators interested in the interface of TB and HIV, with the goal of stimulating inter-CFAR collaborations on HIV/TB research.
This meeting is organized around five working groups: (1) Molecular pathogenesis of TB/HIV co-infection; (2) Immunopathogenesis of co-infection; (3) Diagnosis of TB in HIV infected children and adults; (4) Treatment and clinical trials; and (5) Implementation science.
The goals of this initial meeting are to identify shared research agendas, develop shared CFAR resources, and identify collaborative projects.
The day will consist of brief presentations and open discussions around each topic; presentations by each CFAR on ongoing TB/HIV research efforts and resources; and breakout sessions on each topic followed by development of an inter-CFAR agenda and action plan.
We are pleased to have received generous support from the National Institutes of Health. Special thanks to all the group leaders and to the Baylor College of Medicine at the
University of Texas at Houston CFAR for hosting the meeting.
We hope you enjoy today's meeting.
---- The Inter-CFAR National Meeting Planning Committee
Contents
Agenda 1
HIV/TB Co-infection Projects, Researchers and Inter-CFAR Shared Resources........... 3-18
Participant list 19-20
Agenda
| 8:00-8:30 | Registration and refreshments |
| 8:30- 8:45 | Welcome Remarks/Introductions: |
| 8:45-12:00 | Overview talks to identify key issues and challenges in HIV/TB The goal is to provide an overview of the topic focused on critical unanswered questions and research opportunities (e.g.: topics, models, emerging technology, etc.). The plan is not to have a presentation of research science per se, but to identify needs within the topic. This overview will be presented by the principal group leader and prepared in collaboration with the additional identified/invited leaders (listed below) in that area. We will have 20 minutes presentations and 10 minutes discussion. |
| 8:45-9:15 | Chris Sassetti - Molecular Pathogenesis of TB/HIV Co-infection Michael Weiden |
| 9:15-9:45 | David Canady - Immunology of coinfection Zahra Toossi |
| 9:45-10:15 | Dorothy Lewis - Diagnosis of TB in HIV infected children and adults Carleton Evans |
| 10:15-10:30 | Break |
| 10:30-11:00 | Connie Benson - Treatment and clinical trials in dual infection |
| 11:00-11:30 | Henry Blumberg - Implementation research: delivering prevention, diagnostics and Timothy Sterling - treatment in dual infected populations |
| 11:30-12:00 | Victoria Kasprowicz - Potential CFAR HIV/TB networks in Africa |
| 12:00-12:15 | Hugh Auchincloss Principal Deputy Director, NIAID, NIH View from NIAID - Program priorities; goals for existing resources and networks; potential resources available |
| 12:15-1:30 | Working lunch |
| 1:00- 1:15 | Breakout sessions instructions/set up Dorothy Lewis |
| 1:15-2:45 | Breakout sessions – opportunities for inter-CFAR activities Facilitated by the working group leader:
Group leaders and discussants: Molecular Pathogenesis Immunology Diagnostics Treatment & Clinical Trials Implementation |
| 2:45-3:00 | Afternoon Break |
| 3:00-4:30 | Reconvene: CFAR Agenda & Action Plan Ron Collman and Sarah Fortune Each working group rapporteur will summarize the group's recommendations (5 minutes summary & 5 minutes discussion per group) Final discussion and development of shared CFAR agenda and specific initiatives |